Policy Summit

Register Now for the 2020 Policy Summit!

ASGCT Staff - August 12, 2020

Your registration for the virtual event covers the full 2.5 days of programming Sept. 23-25.

We're excited to announce that registration is NOW OPEN for the virtual 2020 ASGCT Policy Summit! Join us for an exciting program featuring discussions on key policy challenges and opportunities in the development of, access to, and responsible use of gene and cell therapies.

Attendees will have the opportunity to hear from these speakers and more:

  • George Q. Daley, M.D., Ph.D., Dean of the Faculty of Medicine & Caroline Shields Walker Professor of Medicine, Harvard Medical School
  • Jeet Guram, M.D., Senior Advisor in the Office of the Commissioner, FDA
  • Samarth Kulkarni, Ph.D., Chief Executive Officer, CRISPR Therapeutics
  • Sandy Macrae, M.B., Ch.B, Ph.D., Chief Executive Officer of Sangamo Therapeutics
  • Peter Marks, M.D., Ph.D., Director of FDA CBER
  • Michelle McMurry-Heath, M.D., Ph.D., President and CEO of the Biotechnology Innovation Organization (BIO)
  • Tim Scott, U.S. Senator from South Carolina
  • Renee Wegrzyn, Ph.D., Vice President, Business Development, Ginkgo Bioworks

Registration Rates

  • ASGCT Members: $150
  • Non members: $250
  • Associate Members: $25

Register Now!

Share This Page

Related Articles

Policy Summit

Policy Summit’s First Day Focuses on Ethical and Regulatory Issues

ASGCT Staff - September 23, 2020
Policy Summit

Here's How to Access The Policy Summit

ASGCT Staff - September 23, 2020
Policy Summit

Crucial Patient Access Issues Take Center Stage at the Policy Summit

Max G. Bronstein, M.P.P. - September 17, 2020

Peter Marks, M.D., Ph.D., Director of FDA CBER, speaking at the 2019 ASGCT Policy Summit in Washington, D.C.

Policy Summit

Another Can’t-Miss Policy Summit Session: Trial Design Considerations for Gene Therapy for Rare Diseases

Emily Walsh Martin, Ph.D. - September 11, 2020